These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38779578)

  • 21. Regression of Colonic Adenomas After Treatment With Sulindac in Familial Adenomatous Polyposis: A Case With a 2-Year Follow-up Without a Prophylactic Colectomy.
    Kim KY; Jeon SW; Park JG; Yu CH; Jang SY; Lee JK; Hwang HY
    Ann Coloproctol; 2014 Aug; 30(4):201-4. PubMed ID: 25210691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of familial adenomatous polyposis and MUTYH-associated polyposis; new insights.
    Aelvoet AS; Buttitta F; Ricciardiello L; Dekker E
    Best Pract Res Clin Gastroenterol; 2022; 58-59():101793. PubMed ID: 35988966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial.
    Ishikawa H; Mutoh M; Sato Y; Doyama H; Tajika M; Tanaka S; Horimatsu T; Takeuchi Y; Kashida H; Tashiro J; Ezoe Y; Nakajima T; Ikematsu H; Hori S; Suzuki S; Otani T; Takayama T; Ohda Y; Mure K; Wakabayashi K; Sakai T
    Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):474-481. PubMed ID: 33812492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel pathogenic splice acceptor site germline mutation in intron 14 of the APC gene in a Chinese family with familial adenomatous polyposis.
    Wang D; Liang S; Zhang Z; Zhao G; Hu Y; Liang S; Zhang X; Banerjee S
    Oncotarget; 2017 Mar; 8(13):21327-21335. PubMed ID: 28423518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of an aggressive depressed cancer in a case of familial adenomatous polyposis.
    Saito Y; Fujii T; Akasu T; Gotoda T; Kozu T; Saito D; Sano Y
    Endoscopy; 2002 May; 34(5):421-3. PubMed ID: 11972278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endoscopic and chemopreventive management of familial adenomatous polyposis syndrome.
    Stone JK; Mehta NA; Singh H; El-Matary W; Bernstein CN
    Fam Cancer; 2023 Oct; 22(4):413-422. PubMed ID: 37119510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid Rectal Polyposis Development in a Patient With Familial Adenomatous Polyposis.
    Abrams HR; Lee M; Dahdal S; Khalaf N
    ACG Case Rep J; 2020 Oct; 7(10):e00469. PubMed ID: 33134403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary administration of black raspberries modulates arsenic biotransformation and reduces urinary 8-oxo-2'-deoxyguanosine in mice.
    Tu P; Xue J; Bian X; Chi L; Gao B; Leng J; Ru H; Knobloch TJ; Weghorst CM; Lu K
    Toxicol Appl Pharmacol; 2019 Aug; 377():114633. PubMed ID: 31229487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic Metabolite Changes in Wild-type C57BL/6 Mice Fed Black Raspberries.
    Pan P; Skaer CW; Wang HT; Kreiser MA; Stirdivant SM; Oshima K; Huang YW; Young MR; Wang LS
    Nutr Cancer; 2017; 69(2):299-306. PubMed ID: 28094560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ursodeoxycholic acid counteracts celecoxib in reduction of duodenal polyps in patients with familial adenomatous polyposis: a multicentre, randomized controlled trial.
    van Heumen BW; Roelofs HM; Vink-Börger ME; Dekker E; Mathus-Vliegen EM; Dees J; Koornstra JJ; Langers AM; Nagtegaal ID; Kampman E; Peters WH; Nagengast FM
    Orphanet J Rare Dis; 2013 Aug; 8():118. PubMed ID: 23919274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting polyposis severity by proctoscopy: how reliable is it?
    Church J; Burke C; McGannon E; Pastean O; Clark B
    Dis Colon Rectum; 2001 Sep; 44(9):1249-54. PubMed ID: 11584194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factors.
    Giardiello FM; Offerhaus JA; Tersmette AC; Hylind LM; Krush AJ; Brensinger JD; Booker SV; Hamilton SR
    Gut; 1996 Apr; 38(4):578-81. PubMed ID: 8707091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rectal carcinoma in a patient with familial adenomatous polyposis coli after colectomy with ileorectal anastomosis and consecutive chemoprevention with sulindac suppositories].
    Utech M; Brüwer M; Buerger H; Tübergen D; Senninger N
    Chirurg; 2002 Aug; 73(8):855-8. PubMed ID: 12425165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endoscopic management of familial adenomatous polyposis targeting colorectal lesions greater than 5 mm in size: a single-center retrospective study.
    Murano T; Ikematsu H; Shinmura K; Okumura K; Kuwata T; Ushiama M; Yoshida T; Takashima K; Nakajo K; Kadota T; Yoda Y; Oono Y; Yano T
    Fam Cancer; 2023 Jan; 22(1):83-89. PubMed ID: 35930210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telomerase activity and p53 gene mutation in familial polyposis coli.
    Ikeguchi M; Makino M; Kaibara N
    Anticancer Res; 2000; 20(5C):3833-7. PubMed ID: 11268463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Pro-inflammatory and Anti-apoptotic Biomarkers during Experimental Oral Cancer Chemoprevention by Dietary Black Raspberries.
    Oghumu S; Casto BC; Ahn-Jarvis J; Weghorst LC; Maloney J; Geuy P; Horvath KZ; Bollinger CE; Warner BM; Summersgill KF; Weghorst CM; Knobloch TJ
    Front Immunol; 2017; 8():1325. PubMed ID: 29109723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis.
    Samadder NJ; Foster N; McMurray RP; Burke CA; Stoffel E; Kanth P; Das R; Cruz-Correa M; Vilar E; Mankaney G; Buttar N; Thirumurthi S; Turgeon DK; Sossenheimer M; Westover M; Richmond E; Umar A; Della'Zanna G; Rodriguez LM; Szabo E; Zahrieh D; Limburg PJ
    Gut; 2023 Feb; 72(2):256-263. PubMed ID: 35636921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial.
    Samadder NJ; Kuwada SK; Boucher KM; Byrne K; Kanth P; Samowitz W; Jones D; Tavtigian SV; Westover M; Berry T; Jasperson K; Pappas L; Smith L; Sample D; Burt RW; Neklason DW
    JAMA Oncol; 2018 May; 4(5):671-677. PubMed ID: 29423501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients.
    Sinicrope FA; Half E; Morris JS; Lynch PM; Morrow JD; Levin B; Hawk ET; Cohen DS; Ayers GD; Stephens LC;
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):920-7. PubMed ID: 15184247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.